Hot High Dividend Companies To Invest In Right Now

Last week, around 42 companies announced a high dividend. I published all stocks with dividend growth from the recent week in the attached dividend list. In average, stocks from the list of the latest dividend growth stocks have increased their dividend payments by 15.51%.

It�� always good to see how the dividend growth strategy works. Some of the dividend growers have raised their payments forty times and more. The biggest names come from the oil and gas sector. Eni and Total are the two biggest stocks followed by the British spirit maker Diageo.

Five of the results have a double-digit dividend yield and seven yielding above five percent. Analysts and brokerage firms recommend more than half, 26 in total, of the dividend growth stocks.

Here are my favorite dividend growth stocks:


Teva Pharmaceuticals (TEVA) has a market capitalization of $34.16 billion. The company employs 45,948 people, generates revenue of $20.317 billion and has a net income of $1.956 billion. Teva Pharmaceuticals�� EBITDA amounts to $6.055 billion. The EBITDA margin is 29.80% (the operating margin is 10.85% and the net profit margin 9.63%).

10 Best Media Stocks For 2015: Braskem SA (BRKM5)

Braskem SA is a Brazil-based company primarily engaged in the manufacture of basic petrochemical products. The Company operates in five segments: Basic petrochemicals, Polyolefins, Vinyls, International businesses and Chemical Distribution. The Company�� products portfolio includes ethylene, propylene, butadiene, toluene, xylene, benzene, gasoline, diesel oil, liquefied petroleum gas (LPG), as well as thermoplastic resins, such as polyethylene (PE), polypropylene (PP) and polyvinyl chloride (PVC). Additionally, Braskem is also engaged in the import and export of chemicals, petrochemicals and fuels; the production, supply and sale of utilities, such as steam, water, compressed air, industrial gases, as well as the provision of industrial services, and the production, supply and sale of electric energy for its own use and use by other companies. The Company also invests in other companies, either as a partner or shareholder. Advisors' Opinion:

• [By Harry Suhartono]

  Brazil�� Ibovespa rose for a third day as traders pared bets on higher borrowing costs in Brazil, boosting the outlook for companies that sell in the local market. B2W Cia. Digital led gains among retailers, with Lojas Americanas SA (LAME3) and Natura Cosmeticos SA (NATU3) also trading higher. Petrochemicals producer Braskem SA (BRKM5) was the worst performer on the equity gauge after O Estado de S.Paulo reported Petroleo Brasileiro SA (PETR4) is seeking to raise prices of naphtha sold to the company by 5 percent.

Hot High Dividend Companies To Invest In Right Now: Masimo Corporation(MASI)

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising circuit boards, monitors and devices, sensors, and cables; Masimo SafetyNet, a remote monitoring and clinician notification system; and software for Rainbow measurements, as well as other future measurements or features. The company sells its products to hospitals and the emergency medical response organizations through its direct sales force and distributors, as well as to original equipment manufacturer partners in the United States, Europe, the Middle East, Asia, Latin America, Canada, and Australia. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Advisors' Opinion:

• [By Seth Jayson]

  There's no foolproof way to know the future for Masimo (Nasdaq: MASI  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

Hot High Dividend Companies To Invest In Right Now: Salix Pharmaceuticals Ltd (SLXP)

Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company�� products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.

Xifaxan (rifaximin) tablets

Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers��diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.

It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.

In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla�� application related to amorphous rifaximin and Solmag SpA�� application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in addition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.

MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution

MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.

Apriso (mesalamine) extended-release capsules 0.375 gram

Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product�� prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.

Relistor (methylnaltrexone bromide)

Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.

OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets

Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.

Solesta

Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.

Deflux

Deflux is a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.

Fulyzaq (crofelemer) delayed-release tablets

On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.

Giazo (balsalazide disodium) tablets

February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.

Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets

METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.

Azasan (azathioprine) tablets

Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.

Anusol-HC and Proctocort (hydrocortisone) creams and suppositories

The Company acquired the right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.

Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)

Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.

Colazal (balsalazide disodium) capsules

The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.

The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.

Advisors' Opinion:

• [By Garrett Cook]

  Salix Pharmaceuticals (NASDAQ: SLXP) shares shot up 4.52 percent to $167.05 on report of takeover talks with Allergan. Allergan (NYSE: AGN) is set to acquire Salix Pharmaceuticals in a deal probably worth more than $10 billion, according to Dow Jones Newswires.

• [By Garrett Cook]

  Salix Pharmaceuticals (NASDAQ: SLXP) shares shot up 12.54 percent to $138.82 as the company reported that endpoint was met in TARGET 3 study.

  Shares of GoPro (NASDAQ: GPRO) got a boost, shooting up 15.19 percent to $46.71  following an announcement by the Chicago Board Options Exchange (CBOE) that it will list options for GoPro starting Monday, July 7. GoPro shares jumped 13.39% on Monday.

• [By Philip Springer]

  What’s more, earnings estimates for 2014 by Wall Street analysts have increased for seven of the 10 companies over the last three months. Amgen’s are down slightly and those for Celgene and Novo Nordisk are unchanged.
  
  Two of the 10 stocks currently are in the PF Growth Portfolio. Another, Allergan, was sold for a 75 percent long-term gain since its initial recommendation.
  
  As of late February, the 10 stocks profiled carried market capitalizations of roughly $30 billion and up. Here are another four companies to watch: Grifols SA (NSDQ: GRFS), Jazz Pharmaceuticals PLC (NSDQ: JAZZ), Questcor Pharmaceuticals (NSDQ: QCOR) and Salix Pharmaceuticals (NSDQ: SLXP). Each of these four companies is generating rapid revenue and profit growth, and each stock carries a market capitalization of $5 billion or more.
  
  Have a happy and safe Fourth of July weekend!

• [By Anna Prior]

  Salix Pharmaceuticals Ltd.(SLXP) agreed to combine with an Ireland-based unit of Cosmo Pharmaceuticals SpA(COPN.EB) in an inversion deal that is expected to come with tax benefits. Salix shares slipped 5.3% to $130.00 premarket.

Hot High Dividend Companies To Invest In Right Now: Town Sports International Holdings Inc.(CLUB)

Town Sports International Holdings, Inc., together with its subsidiaries, owns and operates fitness clubs in the northeast and mid-Atlantic regions of the United States. Its facilities include cardiovascular equipment; free weight and strength equipment; group exercise and cycling studios; the entertainment system network; locker rooms, including shower facilities and towel services; and other amenities, such as saunas, babysitting, and a pro-shop. The company also provides swimming pools, and racquet and basketball courts; and programs, which include small group training, children?s programs, and other programs targeting adult members. As of December 31, 2011, it operated 160 fitness clubs comprising 108 New York Sports Clubs, 25 Boston Sports Clubs, 18 Washington Sports Clubs, and 6 Philadelphia Sports Clubs, as well as 3 clubs located in Switzerland. The company is based in New York, New York.

Advisors' Opinion:

• [By Seth Jayson]

  Town Sports International Holdings (Nasdaq: CLUB  ) reported earnings on July 24. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Town Sports International Holdings met expectations on revenues and met expectations on earnings per share.

• [By gurujx]

  Town Sports International Holdings Inc (CLUB) Reached the 3-year Low of $5.82

  The prices of Town Sports International Holdings Inc (CLUB) shares have declined to close to the 3-year low of $5.82, which is 62.2% off the 3-year high of $14.96.

• [By John Udovich]

  On Thursday, small cap fitness club owner Life Time Fitness, Inc (NYSE: LTM) lost some weight for investors as analysts gave the stock a workout after its Analyst Day failed to ease their concerns, meanings its worth taking a closer look at the stock along with the performance of Town Sports International Holdings, Inc (NASDAQ: CLUB)�and Steiner Leisure Ltd (NASDAQ: STNR).

Hot High Dividend Companies To Invest In Right Now: Armco Metals Holdings Inc (AMCO)

Armco Metals Holdings, Inc., formerly China Armco Metals, Inc., incorporated on April 25, 2007, is engaged in metal ore trading and distribution and scrap metal recycling. The Company�� s operations are conducted primarily in the People's Republic of China (PRC). In the Company's metal ore trading and distribution business, the Company imports, sells and distributes to the metal refinery industry in the PRC a range of metal ore which includes iron, chrome, nickel, copper and manganese ore, as well as non-ferrous metals, and coal. The Company obtains these raw materials from global suppliers primarily in Brazil, India, Indonesia, Ukraine and the United States and distributes them in the PRC. In addition, it provides sourcing and pricing services for various metals to its network of customers.

The Company�� scrap metal recycling business, it recycles scrap metal at its recycling facility and sell the recycled product to steel mills in China for use in the production of recycled steel. The Company sells processed and non-ferrous ore to end-users, such as specialty steelmakers, foundries, aluminum sheets and ingot manufacturers, copper refineries and smelters, brass and bronze ingot manufacturers, wire and cable producers, utilities and telephone networks. The Company recycles scrap metals at the Facility using both heavy equipment and manual labors. Recycling scrap metal consists of a variety of steps, including collecting, inspecting, sorting, stripping, shearing, cutting, shredding and bailing.

Advisors' Opinion:

• [By James E. Brumley]

  It's still too soon to put it in your portfolio, but Armco Metals Holdings Inc. (NYSE:AMCO) most definitely deserves a place on your watchlist. This Chinese metal stock is poised for a breakout move. It just needs the right nudge, and a little help on a certain front to let AMCO take flight.

Hot High Dividend Companies To Invest In Right Now: Peapack-Gladstone Financial Corporation(PGC)

Peapack-Gladstone Financial Corporation operates as the holding company for Peapack-Gladstone Bank that provides financial, trust, and investment services to individuals and small businesses in New Jersey. The company?s deposit products include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. Its loan portfolio comprises residential and construction mortgages, home equity lines of credit, and other second mortgage loans, as well as commercial loans, including working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, and other forms of asset-based financing. The company also provides foreign and domestic travelers? checks, cashier?s checks, wire transfers, Internet banking, and automated teller machine services. In addition, it offers personal investment management, personal trust administration, estate settlement, income tax, custodial, a nd other financial planning services. Peapack-Gladstone Financial Corporation provides its services through 23 full-service banking offices, including 10 branches in Somerset County, 6 in Morris County, 4 in Hunterdon County, 1 in Middlesex County, and 2 in Union County. The company was founded in 1921 and is based in Bedminster, New Jersey.

Advisors' Opinion:

• [By Alex Planes]

  Since that prediction, Honeywell's begun to branch out in unexpected ways, as it's now working with utilities such as PG&E (NASDAQ: PGC  ) to provide residential energy-management platforms. The "smart grid" is growing in fits and starts, but it's one of the more optimistic corners of tomorrow's economy, so it's good for Honeywell investors to see the company dipping a toe in these waters.